Woodard & CO Asset Management Group Inc Abb Vie Inc. Transaction History

Woodard & CO Asset Management Group Inc

$414 Million
Q3 2024

A detailed history of Woodard & CO Asset Management Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Woodard & CO Asset Management Group Inc holds 8,274 shares of ABBV stock, worth $1.42 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

8,274

Previous 8,240 0.41%

Holding current value

$1.42 Million

Previous $1.41 Million 15.57%

% of portfolio

0.39%

Previous 0.36%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $5,570 - $6,777	34 Added 0.41%	8,274 $1.63 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $30,958 - $36,152	-200 Reduced 2.37%	8,240 $1.41 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $15,982 - $18,210	-100 Reduced 1.17%	8,440 $1.54 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $15,763 - $18,248	-118 Reduced 1.36%	8,540 $1.27 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $15,636 - $19,458	118 Added 1.38%	8,658 $1.17 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $8,676 - $9,992	-60 Reduced 0.7%	8,540 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $22,129 - $26,539	160 Added 1.9%	8,600 $1.39 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $43,350 - $55,112	-315 Reduced 3.6%	8,440 $1.29 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $26,395 - $32,750	-200 Reduced 2.23%	8,755 $1.42 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $18,800 - $23,787	175 Added 1.99%	8,955 $1.21 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $3,436 - $4,033	40 Added 0.46%	8,780 $769,000
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $22,011 - $29,454	300 Added 3.55%	8,740 $858,000
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $7,095 - $10,756	110 Added 1.32%	8,440 $643,000
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $6,491 - $8,122	90 Added 1.09%	8,330 $738,000
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $44,086 - $53,004	700 Added 9.28%	8,240 $624,000
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $54,494 - $67,207	-700 Reduced 8.5%	7,540 $695,000
Q4 2017 Feb 16, 2018	BUY	$89.56 - $98.21 $737,974 - $809,250	8,240	8,240 $797,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.

Account

Woodard & CO Asset Management Group Inc Abb Vie Inc. Transaction History